The analysis showed that there was no significant difference (OR = 0.76, 95% CI, 0.50–1.15; P = 0.20) (Figure 4A); Considering the effect of MHT, we analyzed the effect of EPO combined with MHT on cerebral palsy which includes two RCTs. The gene discussed is EPO; the disease is cerebral palsy.